1. Lau WY. Management of hepatocellular carcinoma. J R Coll Surg Edinb. 2002; 47:389–399.
2. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003; 362:1907–1917.
Article
3. Lau WY. The history of liver surgery. J R Coll Surg Edinb. 1997; 42:303–309.
4. Lau WY. A review on the operative techniques in liver resection. Chin Med J (Engl). 1997; 110:567–570.
5. Ng KK, Poon RT. Radiofrequency ablation for malignant liver tumor. Surg Oncol. 2005; 14:41–52.
Article
6. Khan MR, Poon RT, Ng KK, et al. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma. Arch Surg. 2007; 142:1136–1143.
Article
7. Guglielmi A, Ruzzenente A, Valdegamberi A, et al. Radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma in cirrhosis. J Gastrointest Surg. 2008; 12:192–198.
Article
8. Lencioni R, Cioni D, Crocetti L, Bartolozzi C. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art. Liver Transpl. 2004; 10(2 Suppl 1):S91–97.
Article
9. Lencioni R, Crocetti L. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma. Clin Liver Dis. 2005; 9:301–314.
Article
10. Gillams AR, Lees WR. Radiofrequency ablation of colorectal liver metastases in 167 patients. Eur Radiol. 2004; 14:2261–2267.
Article
11. Rhim H, Lim HK. Radiofrequency ablation of hepatocellular carcinoma: pros and cons. Gut Liver. 2010; 4(Suppl 1):S113–S118.
Article
12. Livraghi T, Solbiati L, Meloni MF, Gazelle GS, Halpern EF, Goldberg SN. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003; 226:441–451.
Article
13. Giorgio A, Tarantino L, de Stefano G, Coppola C, Ferraioli G. Complications after percutaneous saline-enhanced radiofrequency ablation of liver tumors:3-year experience with 336 patients at a single center. AJR Am J Roentgenol. 2005; 184:207–211.
14. Kong WT, Zhang WW, Qiu YD, et al. Major complications after radiofrequency ablation for liver tumors: analysis of 255 patients. World J Gastroenterol. 2009; 15:2651–2656.
Article
15. Mulier S, Mulier P, Ni Y, et al. Complications of radiofrequency coagulation of liver tumours. Br J Surg. 2002; 89:1206–1222.
Article
16. Munene G, Graham JA, Holt RW, Johnson LB, Marshall HP Jr. Biliary-colonic fistula: a case report and literature review. Am Surg. 2006; 72:347–350.
Article
17. Uppot RN, Silverman SG, Zagoria RJ, Tuncali K, Childs DD, Gervais DA. Imaging-guided percutaneous ablation of renal cell carcinoma: a primer of how we do it. AJR Am J Roentgenol. 2009; 192:1558–1570.
Article
18. Satoh H, Matsuyama S, Mashima H, Imoto A, Hidaka K, Hisatsugu T. A case of hepatocolic fistula after percutaneous drainage for a gas-containing pyogenic liver abscess. J Gastroenterol. 1994; 29:782–785.
Article
19. Petersen B, Barkun A, Carpenter S, et al. Technology Assessment Committee, American Society for Gastrointestinal Endoscopy. Tissue adhesives and fibrin glues. Gastrointest Endosc. 2004; 60:327–333.
Article
20. Seewald S, Brand B, Groth S, et al. Endoscopic sealing of pancreatic fistula by using N-butyl-2-cyanoacrylate. Gastrointest Endosc. 2004; 59:463–470.
Article
21. Bae JH, Kim GC, Ryeom HK, Jang YJ. Percutaneous embolization of persistent biliary and enteric fistulas with Histoacryl. J Vasc Interv Radiol. 2011; 22:879–883.
Article